Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 129K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hamad, A. R. A. Articles by Pardoll, D. Search for Related Content PubMed PubMed Citation Articles by Hamad, A. R. A. Articles by Pardoll, D. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                            What's this?

Articles

Abdel Rahim A. Hamad^*, Sean M. O'Herrin, Michael S. Lebowitz, Ananth Srikrishnan, Joan Bieler, Jonathan Schneck, and Drew Pardoll^*

From the ^* Department of Oncology and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

The interaction of the T cell receptor (TCR) with its cognate peptide–major histocompatibility complex (MHC) on the surface of antigen presenting cells (APCs) is a primary event during T cell activation. Here we used a dimeric IE^k-MCC molecule to study its capacity to activate antigen-specific T cells and to directly analyze the role of CD4 in physically stabilizing the TCR–MHC interaction. Dimeric IE^k-MCC stably binds to specific T cells. In addition, immobilized dimeric IE^k-MCC can induce TCR downregulation and activate antigen-specific T cells more efficiently than anti-CD3. The potency of the dimeric IE^k-MCC is significantly enhanced in the presence of CD4. However, CD4 does not play any significant role in stabilizing peptide-MHC–TCR interactions as it fails to enhance binding of IE^k-MCC to specific T cells or influence peptide-MHC–TCR dissociation rate or TCR downregulation. Moreover, these results indicate that dimerization of peptide-MHC class II using an IgG molecular scaffold significantly increases its binding avidity leading to an enhancement of its stimulatory capacity while maintaining the physiological properties of cognate peptide–MHC complex. These peptide-MHC–IgG chimeras may, therefore, provide a novel approach to modulate antigen-specific T cell responses both in vitro and in vivo.

Key Words: T cell stimulation • CD4 coreceptor • major histocompatibility complex multimerization • T cell receptor downregulation

Note added in proof. Recently, Crawford et al. observed no effect of CD4 on binding of tetrameric MHC class II MHC covalent peptide complexes to cognate T cells. (Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kappler. 1998. Immunity. 8:675–682.)

Abbreviations used: Tg, transgenic.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS